These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8100730)

  • 21. What do beta-blockers really do? A view from both sides of the receptor. Based on the Oliver Sharpey Lecture 1992.
    Brown MJ
    J R Coll Physicians Lond; 1993 Oct; 27(4):420-7. PubMed ID: 7904645
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of the lysosomes in the pathogenesis of novodrin lesions of the myocardium].
    Iavorskiĭ OG
    Patol Fiziol Eksp Ter; 1982; (4):83-6. PubMed ID: 7133771
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolving mechanisms of action of beta blockers: focus on nebivolol.
    Mason RP; Giles TD; Sowers JR
    J Cardiovasc Pharmacol; 2009 Aug; 54(2):123-8. PubMed ID: 19528811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-adrenergic receptor desensitization in cardiac hypertrophy and heart failure.
    Choi DJ; Rockman HA
    Cell Biochem Biophys; 1999; 31(3):321-9. PubMed ID: 10736754
    [No Abstract]   [Full Text] [Related]  

  • 25. Isolation of intact lysosomes from human RPE cells and effects of A2-E on the integrity of the lysosomal and other cellular membranes.
    Schütt F; Bergmann M; Holz FG; Kopitz J
    Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):983-8. PubMed ID: 12483320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- and beta 2-adrenoceptors.
    Armour JA
    Can J Cardiol; 1997 Mar; 13(3):277-84. PubMed ID: 9117916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation.
    Bassiakou E; Xanthos T; Papadimitriou L
    Eur J Pharmacol; 2009 Aug; 616(1-3):1-6. PubMed ID: 19555681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of beta receptor blockaders on energy metabolism of the myocardium in experimental hyperthyroidism].
    Otter HP; Rackwitz R; Vogt W; Jahrmärker H
    Verh Dtsch Ges Inn Med; 1974; 80():1086-90. PubMed ID: 4156108
    [No Abstract]   [Full Text] [Related]  

  • 29. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of enzymatic disorganization and membrane labilization of intracellular structures in the manifestation of the biological effects of chemical environmental factors].
    Sidorenko GI; Merkur'eva RV
    Gig Sanit; 1981 Aug; (8):8-12. PubMed ID: 7026370
    [No Abstract]   [Full Text] [Related]  

  • 31. Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts.
    Yong QC; Pan TT; Hu LF; Bian JS
    J Mol Cell Cardiol; 2008 Apr; 44(4):701-10. PubMed ID: 18329040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adrenergic betablockers].
    Alvarez Sabín J
    Rev Neurol; 1995; 23 Suppl 2():S185-9. PubMed ID: 7497284
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of steroid hormones on the stability of isolated lysosomes during freezing].
    Lugovoĭ VI; Kravchenko LP
    Vopr Med Khim; 1980; 26(5):620-3. PubMed ID: 7423877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenergic receptors in heart failure.
    Engelhardt S
    Heart Fail Clin; 2005 Jul; 1(2):183-91. PubMed ID: 17386845
    [No Abstract]   [Full Text] [Related]  

  • 36. Beta3-adrenergic receptor subtype signaling in senescent heart: nitric oxide intoxication or "endogenous" beta blockade for protection?
    Zaugg M; Schaub MC
    Anesthesiology; 2008 Dec; 109(6):956-9. PubMed ID: 19034090
    [No Abstract]   [Full Text] [Related]  

  • 37. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical pharmacology of beta adrenergic blocking drugs.
    McDevitt DG; Shanks RG; Prichard BN
    J R Coll Physicians Lond; 1976 Oct; 11(1):21-34. PubMed ID: 10437
    [No Abstract]   [Full Text] [Related]  

  • 39. Benzodioxanes and quinazolines: probes for characterizing alpha-adrenoreceptors.
    Melchiorre C; Giardinà D; Gulini U; Pigini M; Quaglia W
    Farmaco Sci; 1988 Dec; 43(12 Suppl):1141-52. PubMed ID: 2907741
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibition of lysosomal lipases by chlorpromazine: a possible mechanism of stabilization.
    Ruth RC; Owens K; Weglicki WB
    J Pharmacol Exp Ther; 1980 Mar; 212(3):361-7. PubMed ID: 7359339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.